Johnny Duerinck, MD, PhD, is neurosurgeon and clinical researcher at the University Hospital Brussels (UZ Brussel). He graduated as a medical doctor from VUB in 2007 and became neurosurgeon at UZ Brussel in 2013. His training in neurosurgery was marked by a special interest in neuro-oncology. He obtained his PhD in medical sciences for his neuro-oncological research in 2017 and continues to conduct clinical research in this field, with currently a focus on immune therapy and innovative strategies in drug delivery to the central nervous system. He is also involved in clinical trials at the European level as the current chair of the EORTC Brain Tumor Group Neurosurgery Committee and the EANS Neuro-oncology section. He also has a special long-standing interest in new technologies and their application in health care, culminating in a quickly expanding series of multidisciplinary projects in augmented and virtual reality and artificial intelligence.
He has a supervising role within the Tumorscope project and focuses on the predictive value of clinical, imaging and molecular exams with regards to prognosis of brain tumors in general and effectiveness of immune therapy specifically.